scispace - formally typeset
Z

Zacharoula Nikolakopoulou

Researcher at National Institutes of Health

Publications -  10
Citations -  778

Zacharoula Nikolakopoulou is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Cardiopulmonary bypass & Chronic myelogenous leukemia. The author has an hindex of 6, co-authored 9 publications receiving 601 citations. Previous affiliations of Zacharoula Nikolakopoulou include Imperial College London & Queen Mary University of London.

Papers
More filters
Journal ArticleDOI

Epigenome-wide association study of body mass index, and the adverse outcomes of adiposity

Simone Wahl, +123 more
- 05 Jan 2017 - 
TL;DR: In this article, the authors used epigenome-wide association to show that body mass index (BMI), a key measure of adiposity, is associated with widespread changes in DNA methylation.
Journal ArticleDOI

Omega-3 polyunsaturated fatty acids selectively inhibit growth in neoplastic oral keratinocytes by differentially activating ERK1/2

TL;DR: EPA specifically inhibits SCC growth and development by creating a sustained signalling imbalance to amplify the EGFR/ERK/p90RSK pathway in neoplastic keratinocytes to a supraoptimal level, supporting the chemopreventive potential of EPA, whose toxicity to normal cells might be reduced further by blocking its metabolism to DHA.
Journal ArticleDOI

Somatic variants in epigenetic modifiers can predict failure of response to imatinib but not to second generation tyrosine kinase inhibitors

TL;DR: The data suggest that identification of somatic variants at diagnosis facilitates stratification into imatinib responders/non-responders, thereby allowing earlier use of second-generation tyrosine kinase inhibitors, which, in turn, may overcome the negative impact of such variants on disease progression.
Journal ArticleDOI

The induction of apoptosis in pre-malignant keratinocytes by omega-3 polyunsaturated fatty acids docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) is inhibited by albumin.

TL;DR: It is shown for the first time that omega-3 PUFA inhibit the growth and induce apoptosis of pre-malignant keratinocytes and identified albumin as a major antagonistic factor in serum that could limit their effectiveness at pharmacologically-achievable doses.